Lansoprazole Capsule, Delayed Release
Product Images NDC 63629-2341

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 63629-2341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1.jpg (Figure 1)

The text describes the mean severity of day heartburn for evaluable patients by study day. The severity is rated on a scale from 0 to 3, where 3 indicates a severe heartburn and 0 indicates no heartburn. The study compares the effectiveness of a placebo with two different doses of Lansoprazole, a drug used to treat acid reflux. The data is presented graphically over a period of 25 days from the start of the treatment.*

FDA Label Image

Figure-2.jpg (Figure 2)

This is a table showing the mean severity of night heartburn for evaluable patients in a study. The severity is measured on a scale of 0 (none) to 3 (severe) and the data is presented for patients taking a placebo as well as those taking Lansoprazole in 15 mg and 30 mg doses. The data is tracked over 18 days from the start of treatment.*

FDA Label Image

Formula-structure.jpg (Image 01)

FDA Label Image

Label (Lbl636292341)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.